There is limited and inconclusive information regarding the influence of the modality of renal replacement therapy on the atherosclerotic burden of patients on dialysis. The aim of this study was to compare the prevalence of asymptomatic atheromatous carotid disease, as also its rate of progression and cardiovascular outcomes, in two matched populations of patients treated with hemodialysis (HD) and peritoneal dialysis (PD).
The NEFRONA study is funded by a research grant from AbbVie.
Inglés
Public Library of Science
Reproducció del document publicat a https://doi.org/10.1371/journal.pone.0186921
Plos One, 2017, vol. 12, núm. 11, p. 1-16
http://hdl.handle.net/10459.1/65137
cc-by (c) Borràs et al., 2017
http://creativecommons.org/licenses/by/4.0/
Documents de recerca [17848]